Spectrum News: Doctor on frontline of COVID-19 pandemic and protests
UC infectious disease expert fights for social justice through medicine
Carl Fichtenbaum, MD, of the Division of Infectious Diseases at the UC College of Medicine is one of the leaders of UC's efforts to battle the COVID-19 pandemic. Spectrum News profiled Fichtenbaum, highlighting his mission of social justice through medicine.
Carl Fichtenbaum, MD, with his guitar. Photo/Lisa Ventre/UC Creative + Brand
Fichtenbaum says he was heavily influenced by his parents, as they fought against social injustice in the 60s. So being an infectious disease doctor seemed to be the right fit.
“That wanting to help people and wanting to make a difference and so I think that’s what got me interested in infectious diseases," he said.
That’s why during one of the most stressful times in his career, he still made sure to make his voice heard this summer after George Floyd’s death.
“I think it’s very important to speak up whenever you hear about any sort of social injustice. Injustice for one is an injustice for all," he said.
Lead photo Joe Fuqua II/UC Creative + Brand
Impact Lives Here
The University of Cincinnati is leading public urban universities into a new era of innovation and impact. Our faculty, staff and students are saving lives, changing outcomes and bending the future in our city's direction. Next Lives Here.
Stay up on all UC's COVID-19 stories, read more #UCtheGood content, or take a UC virtual visit and begin picturing yourself at an institution that inspires incredible stories.
Related Stories
The Last Show with David Cooper discusses AI in education with UC’s Joshua Lambert
April 12, 2026
The Last Show with David Cooper, a global news podcast, featured Joshua Lambert, PhD, a professor and biostatistician in UC College of Nursing to discuss his latest research on using artificial intelligence for student advising.
UC enrolls first patients in clinical trial for prosthetic joint infections
April 10, 2026
The University of Cincinnati has enrolled the first patients in Peptilogics’ RETAIN clinical trial, testing an investigational drug for prosthetic joint infections after total knee replacement to reduce repeat surgeries and infection recurrence.
Long before machine guns, ancient Romans used this rapid-fire weapon
April 9, 2026
Smithsonian highlights research by UC Classics Professor Steven Ellis, who supervised archaeological work in the Porta Stabia neighborhood of Pompeii.